Tecentriq®

Immunotherapy Shows Promise for TNBC Patients

May 13, 2019 at 04:25 pm by Staff

FDA Approves Tecentriq® as First Immunotherapy Regimen for Breast Cancer A breakthrough therapy is offering unprecedented hope to women with metastatic triple negative breast.... Read More